Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

MPH.L (MPH) Share News

Mereo Agrees With US FDA On Phase Three Trial Design For Acumapimod

15th Apr 2019 10:07

LONDON (Alliance News) - Mereo BioPharma Group PLC said on Monday it has concluded an end of Phase Two meeting with the US Food & Drug Administration regarding acumapimod as a treatment for of Read More

Mereo BioPharma Scures Further Acceptances From OncoMed Shareholders

15th Mar 2019 16:57

LONDON (Alliance News) - Mereo BioPharma Group PLC on Friday said it has now received support agreements in respect of 21.1% of OncoMed Pharmaceuticals Inc's shares and expects to complete the Read More

Mereo BioPharma Withdraws US Listing Application On OncoMed Deal (ALLIPO)

22nd Feb 2019 14:35

LONDON (Alliance News) - Mereo BioPharma Group PLC said Friday it has requested the withdrawal of its US IPO application as it continues to work on its business combination with US pharmaceutical Read More

Mereo BioPharma Founding Director Departs Before OncoMed Combination

11th Feb 2019 12:44

LONDON (Alliance News) - Mereo BioPharma Group PLC on Monday announced the immediate departure of founding board director Frank Armstrong prior to Mereo's combination with US firm OncoMed was Read More

Scancell Appoints New Head Of Research And Manufacturing Divisions

21st Jan 2019 12:58

LONDON (Alliance News) - Scancell Holdings PLC on Monday said it appointed two new executives as head of research and head of manufacturing.Samantha Paston joined Scancell as head of in She Read More

Mereo BioPharma To Acquire US Oncology Firm In All Stock Deal

5th Dec 2018 14:33

LONDON (Alliance News) - Mereo BioPharma Group PLC on Wednesday said it will buy US oncology-focused clinical stage biopharmaceutical business OncoMed Pharmaceuticals Inc via a all-stock deal at a Read More

Mereo BioPharma Doses First Patient In Phase Two MPH-966 Study

5th Nov 2018 12:26

LONDON (Alliance News) - Rare disease pharmaceutical company Mereo Biopharma Group PLC said on Monday it has has dosed its first patient in its Phase 2 clinical study of MPH-966, which is for the Read More

Mereo Completes Patient Enrolment In Brittle Bone Disease Drug Trial

15th Oct 2018 11:20

LONDON (Alliance News) - Mereo Biopharma Group PLC on Monday said it has completed patient enrolment in its phase 2b clinical study of its drug BPS-804, or Setrusumab, which is being conducted in Read More

Mereo BioPharma Completes Positive Revision Of Credit Facility Terms (ALLISS)

1st Oct 2018 13:15

LONDON (Alliance News) - Mereo BioPharma Group PLC said Monday that it completed a revision of the terms of its credit facility with Silicon Valley Bank and Kreos Capital.The revised terms Read More

Mereo BioPharma Considering Fundraise As Interim Loss Narrows

8th Aug 2018 12:53

LONDON (Alliance News) - Mereo BioPharma Group PLC said Wednesday it continues to make progress on "all fronts" after narrowing its interim loss.For the six months to June 30, the Read More

UK Shareholder Meetings Calendar - Next 7 Days

14th Jun 2018 14:40

Friday 15 JuneJD Sports Fashion (re acquisition of The Finish Line)MP Evans GroupBaker Steel 18 (re 19 Read More

Mereo BioPharma Looks To Broaden Shareholder Base (ALLISS)

29th May 2018 12:31

LONDON (Alliance News) - Mereo BioPharma Group PLC said Tuesday it placed 50,076 shares at 300 pence each.Following admission to trading of the new shares, which is expected to occur on 1, Read More

Mereo BioPharma Halts Listing On Nasdaq Due To Market Conditions (ALLIPO)

26th Apr 2018 13:36

LONDON (Alliance News) - Mereo BioPharma Group PLC said on Thursday it has decided to postpone its proposed listing of American depository shares on the Nasdaq Global Market.Mereo said the Read More

Mereo BioPharma Hails Positive BGS-649 Phase II Clinical Trial Data

19th Mar 2018 13:14

LONDON (Alliance News) - Mereo BioPharma Group PLC said Monday it had received positive top-line data for its phase II clinical trial for hypogonadotropic hypogonadism in said Read More

Diurnal Hires Outgoing Mereo BioPharma Finance Chief Bungay

12th Jan 2017 09:04

Mereo Biopharma Progresses Drug Candidates In Maiden Interim Period

16th Sep 2016 10:15

UK Shareholder Meetings Calendar - Next 7 Days

11th Jul 2016 15:07

Mereo Biopharma Gets European Approval For Bone Disorder Treatment

30th Jun 2016 08:07

Mereo Biopharma Shares Up 22% As It Starts Trading On AIM (ALLIPO)

9th Jun 2016 08:36

Mereo BioPharma Raises GBP14.8 Million Ahead Of AIM Admission (ALLIPO)

6th Jun 2016 07:43

FTSE 100 Latest

Value10,559.58

Change-49.48